Skip to main content

Find Clinical Trials

Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

126 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Recruiting

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

NCT04380740

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: City Of Hope National Medical Center Duarte, California, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory University/Winship Cancer Center Atlanta, Georgia, United States

Children's Healthcare of Atlanta Atlanta, Georgia, United States

View all 15 locations

View Trial Details

Recruiting

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

NCT06008808

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Graft-versus-host-disease, +1 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

NCT04337515

Conditions: Graft vs Host Disease, Graft-versus-host-disease, Immune System Diseases
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

NCT05236062

Conditions: Acute-graft-versus-host Disease, Bronchial Diseases, Bronchiolitis, +10 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Fatigue and Cognitive Dysfunction Due to Synaptopathy or Graft Versus Host (GVH) Disease in the Brain.

NCT07365696

Conditions: Cognition Disorders, Cognitive Dysfunction, Fatigue, +6 more
Locations: Ksenia Boriskina Stockholm, Sweden

View Trial Details

Recruiting

IS-free Treg HaploHCT

NCT04678401

Conditions: Bone Marrow Diseases, Graft vs Host Disease, Hematologic Diseases, +11 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

NCT06681922

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Zuckerberg Cancer Center Lake Success, New York, United States

View Trial Details

Recruiting

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367

Conditions: Cutaneous T-Cell Lymphoma, Graft Rejection, Graft vs Host Disease, +11 more
Locations: Centre Hospitalier Universitaire de Besançon Besançon, France

View Trial Details

Recruiting

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

NCT06568328

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Recruiting

oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort

NCT05170347

Conditions: Cancer, Graft vs Host Disease, Haematological Malignancy, +6 more
Locations: Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong Hong Kong

View Trial Details